IS8522A - Ný M3 múskarínasetýlkólínviðtakamótlyf - Google Patents
Ný M3 múskarínasetýlkólínviðtakamótlyfInfo
- Publication number
- IS8522A IS8522A IS8522A IS8522A IS8522A IS 8522 A IS8522 A IS 8522A IS 8522 A IS8522 A IS 8522A IS 8522 A IS8522 A IS 8522A IS 8522 A IS8522 A IS 8522A
- Authority
- IS
- Iceland
- Prior art keywords
- new
- receptor antagonists
- acetylcholine receptor
- muscarinic acetylcholine
- muscarinic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/46—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52676603P | 2003-12-03 | 2003-12-03 | |
| PCT/US2004/040668 WO2005055941A2 (en) | 2003-12-03 | 2004-12-03 | Novel m3 muscarinic acetylcholine receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS8522A true IS8522A (is) | 2006-06-26 |
Family
ID=34676649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS8522A IS8522A (is) | 2003-12-03 | 2006-06-26 | Ný M3 múskarínasetýlkólínviðtakamótlyf |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070179180A1 (xx) |
| EP (1) | EP1694327A4 (xx) |
| JP (1) | JP2007513182A (xx) |
| KR (1) | KR20060123414A (xx) |
| CN (1) | CN1913895A (xx) |
| AR (1) | AR046783A1 (xx) |
| AU (1) | AU2004296208A1 (xx) |
| BR (1) | BRPI0417343A (xx) |
| CA (1) | CA2549273A1 (xx) |
| IL (1) | IL176078A0 (xx) |
| IS (1) | IS8522A (xx) |
| MA (1) | MA28218A1 (xx) |
| MX (1) | MXPA06006256A (xx) |
| NO (1) | NO20063032L (xx) |
| PE (1) | PE20050861A1 (xx) |
| RU (1) | RU2006123418A (xx) |
| TW (1) | TW200530226A (xx) |
| UY (1) | UY28646A1 (xx) |
| WO (1) | WO2005055941A2 (xx) |
| ZA (1) | ZA200604485B (xx) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR045914A1 (es) * | 2003-07-17 | 2005-11-16 | Glaxo Group Ltd | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
| AU2004281167A1 (en) * | 2003-10-17 | 2005-04-28 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists field of the invention |
| AR046225A1 (es) * | 2003-11-04 | 2005-11-30 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion |
| EP1725236A4 (en) * | 2004-03-11 | 2009-05-13 | Glaxo Group Ltd | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS |
| EP1725564A4 (en) * | 2004-03-17 | 2007-09-12 | Glaxo Group Ltd | ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR |
| JP2007529511A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | Ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| UY28871A1 (es) | 2004-04-27 | 2005-11-30 | Glaxo Group Ltd | Antagonistas del receptor de acetilcolina muscarinico |
| WO2005112644A2 (en) * | 2004-05-13 | 2005-12-01 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| TW200630337A (en) * | 2004-10-14 | 2006-09-01 | Euro Celtique Sa | Piperidinyl compounds and the use thereof |
| JP2008520579A (ja) * | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規ｍ３ムスカリン性アセチルコリン受容体アンタゴニスト |
| US20080275079A1 (en) * | 2005-08-02 | 2008-11-06 | Glaxo Group Limited | M3 Muscarinic Acetylcholine Receptor Antagonists |
| US7767691B2 (en) | 2005-08-18 | 2010-08-03 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists containing an azoniabiocyclo[2.2.1] heptane ring system |
| WO2007110449A1 (en) * | 2006-03-29 | 2007-10-04 | Euro-Celtique S.A. | Benzenesulfonamide compounds and their use |
| US8937181B2 (en) * | 2006-04-13 | 2015-01-20 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| TW200815353A (en) * | 2006-04-13 | 2008-04-01 | Euro Celtique Sa | Benzenesulfonamide compounds and their use |
| RU2452728C2 (ru) * | 2007-02-23 | 2012-06-10 | Тереванс, Инк. | Четвертичные аммониевые дифенилметилсоединения, применимые в качестве антагонистов мускариновых рецепторов |
| WO2008124118A1 (en) * | 2007-04-09 | 2008-10-16 | Purdue Pharma L.P. | Benzenesulfonyl compounds and the use therof |
| WO2009040659A2 (en) * | 2007-09-28 | 2009-04-02 | Purdue Pharma L.P. | Benzenesulfonamide compounds and the use thereof |
| AR070564A1 (es) | 2008-02-06 | 2010-04-21 | Glaxo Group Ltd | Derivados de 1h-pirazolo[3,4-b]piridin-5-ilo,inhibidores de fosfodiesterasas pde4 y antagonistas de receptores muscarinicos de acetilcolina(machr), utiles en el tratamiento y/o profilaxis de enfermedades respiratorias y alergicas,y composiciones farmaceuticas que los comprenden |
| TW201000476A (en) | 2008-02-06 | 2010-01-01 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| PE20091563A1 (es) | 2008-02-06 | 2009-11-05 | Glaxo Group Ltd | Farmacoforos duales - antagonistas muscarinicos de pde4 |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6482837B1 (en) * | 1998-04-24 | 2002-11-19 | University Of Rochester | Antimuscarinic compounds and methods for treatment of bladder diseases |
| WO2001010439A1 (fr) * | 1999-08-04 | 2001-02-15 | Teijin Limited | Antagonistes d'amine cyclique ccr3 |
| DE10063008A1 (de) * | 2000-12-16 | 2002-06-20 | Merck Patent Gmbh | Carbonsäureamidderivate |
| DE10201550A1 (de) * | 2002-01-17 | 2003-07-31 | Merck Patent Gmbh | Phenoxy-Piperidine |
-
2004
- 2004-12-01 PE PE2004001184A patent/PE20050861A1/es not_active Application Discontinuation
- 2004-12-01 AR ARP040104478A patent/AR046783A1/es unknown
- 2004-12-01 TW TW093136973A patent/TW200530226A/zh unknown
- 2004-12-01 UY UY28646A patent/UY28646A1/es unknown
- 2004-12-03 JP JP2006542826A patent/JP2007513182A/ja active Pending
- 2004-12-03 MX MXPA06006256A patent/MXPA06006256A/es not_active Application Discontinuation
- 2004-12-03 EP EP04813056A patent/EP1694327A4/en not_active Withdrawn
- 2004-12-03 US US10/581,229 patent/US20070179180A1/en not_active Abandoned
- 2004-12-03 WO PCT/US2004/040668 patent/WO2005055941A2/en active Application Filing
- 2004-12-03 CA CA002549273A patent/CA2549273A1/en not_active Abandoned
- 2004-12-03 KR KR1020067013263A patent/KR20060123414A/ko not_active Application Discontinuation
- 2004-12-03 BR BRPI0417343-0A patent/BRPI0417343A/pt not_active Application Discontinuation
- 2004-12-03 CN CNA2004800412735A patent/CN1913895A/zh active Pending
- 2004-12-03 AU AU2004296208A patent/AU2004296208A1/en not_active Abandoned
- 2004-12-03 RU RU2006123418/04A patent/RU2006123418A/ru not_active Application Discontinuation
-
2006
- 2006-05-31 IL IL176078A patent/IL176078A0/en unknown
- 2006-06-01 ZA ZA200604485A patent/ZA200604485B/en unknown
- 2006-06-02 MA MA29069A patent/MA28218A1/fr unknown
- 2006-06-26 IS IS8522A patent/IS8522A/xx unknown
- 2006-06-29 NO NO20063032A patent/NO20063032L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY28646A1 (es) | 2005-06-30 |
| JP2007513182A (ja) | 2007-05-24 |
| KR20060123414A (ko) | 2006-12-01 |
| CA2549273A1 (en) | 2005-06-23 |
| WO2005055941A2 (en) | 2005-06-23 |
| TW200530226A (en) | 2005-09-16 |
| EP1694327A2 (en) | 2006-08-30 |
| WO2005055941A3 (en) | 2006-02-16 |
| ZA200604485B (en) | 2007-11-28 |
| RU2006123418A (ru) | 2008-01-10 |
| BRPI0417343A (pt) | 2007-03-13 |
| MXPA06006256A (es) | 2006-08-23 |
| CN1913895A (zh) | 2007-02-14 |
| EP1694327A4 (en) | 2009-11-25 |
| AU2004296208A1 (en) | 2005-06-23 |
| IL176078A0 (en) | 2006-10-05 |
| MA28218A1 (fr) | 2006-10-02 |
| AR046783A1 (es) | 2005-12-21 |
| NO20063032L (no) | 2006-08-30 |
| PE20050861A1 (es) | 2005-12-10 |
| US20070179180A1 (en) | 2007-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS8522A (is) | Ný M3 múskarínasetýlkólínviðtakamótlyf | |
| IS8515A (is) | Ný M3 múskarínasetýlkólínviðtakamótlyf | |
| CY2014043I2 (el) | Ανταγωνιστες μουσκαρινικου υποδοχεα ακετυλοχολινης | |
| DK1682142T3 (da) | M3-muscarin-acetylcholin-receptor-antagonister | |
| DK1677795T3 (da) | Muskarine acetylcholin-receptor-antagonister | |
| EP1725236A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| EP1957075A4 (en) | NOVEL ANTAGONISTS OF ACETYLCHOLINE M3 TYPE MUSCARINIC RECEPTORS | |
| IL172911A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| EP1827439A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| IL172912A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| ZA200602783B (en) | Muscarinic acetylcholine receptor antagonists | |
| IL176775A0 (en) | Muscarinic acetylcholine receptor antagonists | |
| EP1749012A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1824483A4 (en) | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS | |
| EP1725240A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1937230A4 (en) | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS | |
| EP1937267A4 (en) | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS | |
| EP1765339A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1648460A4 (en) | ANTAGONISTS OF MUSCARIN ACETYLCHOLIN RECEPTOR | |
| EP1781104A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1751089A4 (en) | NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS | |
| EP1725241A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC M3 RECEPTOR | |
| EP1781103A4 (en) | ANTAGONISTS OF THE ACETYLCHOLINE MUSCARINIC RECEPTOR | |
| EP1725564A4 (en) | ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR |